List of Excipients in API hydrocortisone probutate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrocortisone probutate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | ANHYDROUS TRISODIUM CITRATE | |
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | BUTYLPARABEN | |
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | CITRIC ACID MONOHYDRATE | |
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | GLYCERYL MONOSTEARATE | |
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | GLYCERYL STEARATE SE | |
PharmaDerm a division of Fougera Pharmaceuticals Inc | PANDEL | hydrocortisone probutate | 10337-153 | LIGHT MINERAL OIL | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for hydrocortisone probutate
Excipient focus: ANHYDROUS CITRIC ACID
hydrocortisone probutate drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS TRISODIUM CITRATE
hydrocortisone probutate drug variants containing ANHYDROUS TRISODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing ANHYDROUS TRISODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLPARABEN
hydrocortisone probutate drug variants containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
hydrocortisone probutate drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
hydrocortisone probutate drug variants containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL STEARATE SE
hydrocortisone probutate drug variants containing GLYCERYL STEARATE SE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing GLYCERYL STEARATE SE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
hydrocortisone probutate drug variants containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing LIGHT MINERAL OIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
hydrocortisone probutate drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PEG-20 STEARATE
hydrocortisone probutate drug variants containing PEG-20 STEARATE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing PEG-20 STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
hydrocortisone probutate drug variants containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
hydrocortisone probutate drug variants containing POLYSORBATE 60
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing POLYSORBATE 60
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocortisone probutate drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
hydrocortisone probutate drug variants containing SORBITAN MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing SORBITAN MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
hydrocortisone probutate drug variants containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocortisone probutate drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
hydrocortisone probutate drug variants containing WHITE PETROLATUM
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | hydrocortisone probutate | 62559-325 |
>Company | >Ingredient | >NDC |
hydrocortisone probutate drug variants not containing WHITE PETROLATUM
Company | Ingredient | NDC |
---|---|---|
PharmaDerm a division of Fougera Pharmaceuticals Inc | hydrocortisone probutate | 10337-153 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.